Therapeutic Potential of High Mobility Group Box-1 in Ischemic Injury and Tissue Regeneration

By  

Current Vascular Pharmacology, Vol. 9, Iss. 6, 2011-11 ,pp. : 677-681

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of ephrin-B1 in hepatocellular carcinoma: possible involvement in neovascularization

By Sawai Y.   Tamura S.   Fukui K.   Ito N.   Imanaka K.   Saeki A.   Sakuda S.   Kiso S.   Matsuzawa Y.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 991-996

Elsevier

Access to resources Recommend Favorite

Expression and Prognostic Value of ZNRD1 in Esophageal Squamous Cell Carcinoma

By Zhao Yunping   Hong Liu   Wang Ruwen   Fan Daiming  

Digestive Diseases and Sciences, Vol. 54, Iss. 3, 2009-03 ,pp. : 586-592

Springer Publishing Company

Access to resources Recommend Favorite

Betaine Protects Against High-Fat-Diet-Induced Liver Injury by Inhibition of High-Mobility Group Box 1 and Toll-Like Receptor 4 Expression in Rats

By Zhang Wei   Wang Lu-wen   Wang Li-kun   Li Xun   Zhang Hong   Luo Li-Ping   Song Jin-Chun   Gong Zuo-jiong  

Digestive Diseases and Sciences, Vol. 58, Iss. 11, 2013-11 ,pp. : 3198-3206

Springer Publishing Company

Access to resources Recommend Favorite

High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease

By Hoshina T.   Kusuhara K.   Ikeda K.   Mizuno Y.   Saito M.   Hara T.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 6, 2008-01 ,pp. : 445-449

Informa Healthcare

Access to resources Recommend Favorite